Lisa Schlender
Lisa Schlender publishes mostly in Cardiology and Cardiovascular Medicine, Nutrition and Dietetics and Internal Medicine, on topics such as Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management and Vitamin K Research Studies.
- World rank
- #5,133,053 of 7,710,434 ranked researchers
- Rank in Spain
- #119,958 of 204,306
- Works
- 30
- Citations
- 159
- Citations per work
- 5.3
What does Lisa Schlender research?
Lisa Schlender's work is mostly in Medicine (71%), Nursing (22%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2893.8%
- Life Sciences26.3%
- 1Cardiology and Cardiovascular Medicine39% of their works
- 2Nutrition and Dietetics22% of their works
- 3Internal Medicine18% of their works
- 4Endocrinology, Diabetes and Metabolism12% of their works
- 5Molecular Biology6% of their works
- 6Family Practice2% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Vitamin K Research Studies
- Blood Pressure and Hypertension Studies
- Heart rate and cardiovascular health
- Metabolism, Diabetes, and Cancer
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Lisa Schlender's research?
The keywords of their largest research topics: Risk Factors, Cardiovascular Disease, Anticoagulant Therapy, Atrial Fibrillation, Antithrombotic Therapy, Bone Health, Diabetes Mellitus and Hypertension.
- Type 2 Diabetes
- Metabolic Syndrome
- Cardiovascular Outcomes
- Resting Heart Rate
- Blood Pressure
- Heart Failure
- Vitamin K
- Hypertension
- Bone Health
- Atrial Fibrillation
- Cardiovascular Disease
- Risk Factors
- Anticoagulant Therapy
- Antithrombotic Therapy
- Diabetes Mellitus
- Venous Thromboembolism
- Clinical Guidelines
- Antihypertensive Drugs
- Ivabradine
- AMP-Activated Protein Kinase
- Diabetes
- Metformin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Risk Factors222 topics
- Cardiovascular Disease193 topics
- Anticoagulant Therapy151 topic
- Atrial Fibrillation151 topic
- Antithrombotic Therapy141 topic
- Bone Health141 topic
- Diabetes Mellitus142 topics
- Hypertension142 topics
- Venous Thromboembolism141 topic
- Vitamin K141 topic
- Clinical Guidelines132 topics
- Heart Failure112 topics
- Antihypertensive Drugs81 topic
- Blood Pressure81 topic
- Ivabradine61 topic
- Resting Heart Rate61 topic
- AMP-Activated Protein Kinase51 topic
- Cardiovascular Outcomes51 topic
- Diabetes51 topic
- Metabolic Syndrome51 topic
- Metformin51 topic
- Type 2 Diabetes51 topic
Where does Lisa Schlender work?
Lisa Schlender's main affiliation in the publication record is Parc de Salut, Spain.
How many publications and citations does Lisa Schlender have?
OpenAlex counts 30 works and 159 citations for Lisa Schlender, an h-index of 4, ranking #5,133,053 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lisa Schlender. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.